Bacterium produces “organic dishwashing liquid” to degrade oil
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Jul-2025 04:11 ET (19-Jul-2025 08:11 GMT/UTC)
The marine bacterium Alcanivorax borkumensis feeds on oil, multiplying rapidly in the wake of oil spills, and thereby accelerating the elimination of the pollution, in many cases. It does this by producing an “organic dishwashing liquid” which it uses to attach itself to oil droplets. Researchers from the University of Bonn, RWTH Aachen University, Heinrich Heine University Düsseldorf and research center Forschungszentrum Jülich have now discovered the mechanism by which this “organic dishwashing liquid” is synthesized. Published in the prominent international journal Nature Chemical Biology, the research findings could allow the breeding of more efficient strains of oil-degrading bacteria.
This study reports two cryo-EM structures of the Nipah virus (NiV) polymerase L-P complex in its full-length and truncated forms. These structures elucidate the RNA-dependent RNA polymerase (RdRp) and polyribonucleotidyl transferase (PRNTase) domains of the L protein, as well as the tetrameric P protein bundle bound to the L-RdRp. This work establishes a foundational framework for understanding the NiV polymerase mechanism and provides critical insights for the rational design of antiviral therapeutics targeting the polymerase complex
In neurodegenerative diseases such as Alzheimer's or Parkinson's, proteins accumulate in the body's cells, fold incorrectly and clump together to form larger aggregates. Normally, cells are able to remove these aggregates themselves. However, if a certain enzyme is blocked, this clean-up process no longer works. This is shown in a new study by an international research team led by the University of Würzburg. The new findings provide a better understanding of the molecular basis of these processes.
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG have announced promising outcomes from a Phase II clinical trial of a novel cancer immunotherapy, PRL3-zumab. Published in Cell Reports Medicine, the study shows PRL3-zumab safely slows disease progression in patients with advanced solid cancers unresponsive to existing treatments.
The North Korean government engages in unsustainable and illegal wildlife trade, which includes species protected under its own laws and poses a threat to biodiversity recovery in the region, finds a groundbreaking new study by UCL researchers.